Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period - Stiehl, A; Walker, S; Stiehl, L; Rudolph, G; Hofmann, W J; Theilmann, L (J Hepatol, 1994)